Back
Poseida Therapeutics Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
45
PSTX
Poseida Therapeutics
Last Price:
2.75
Seasonality Move:
20.58%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Poseida Therapeutics Price Quote
$2.75
-0.01 (-14.33%)
(Updated: November 16, 2024 at 5:34 AM ET)
Poseida Therapeutics Key Stats
Sell
45
Poseida Therapeutics (PSTX)
is a Sell
Day range:
$2.73 - $3.28
52-week range:
$1.87 - $4.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.06
P/B ratio:
3.59%
Volume:
699.9K
Avg. volume:
517.8K
1-year change:
24.89%
Market cap:
$312.9M
Revenue:
$64.7M
EPS:
$-0.62
How Much Does Poseida Therapeutics Make?
-
How Much Are Poseida Therapeutics's Sales Annually?
PSTX Revenues are $64.7M -
How Much Profit Does Poseida Therapeutics's Make A Year?
PSTX net income is -$123.4M
Is Poseida Therapeutics Growing As A Company?
-
What Is Poseida Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 6.67% -
What Is Poseida Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Poseida Therapeutics Stock Price Performance
-
Did Poseida Therapeutics Stock Go Up Last Month?
Poseida Therapeutics share price went up by 8.66% last month -
Did PSTX's Share Price Rise Over The Last Year?
PSTX share price rose by 24.89% over the past 1 year
What Is Poseida Therapeutics 52-Week High & Low?
-
What Is Poseida Therapeutics’s 52-Week High Share Price?
Poseida Therapeutics has traded as high as $4.27 over the past 52 weeks -
What Is Poseida Therapeutics’s 52-Week Low Share Price?
Poseida Therapeutics has traded as low as $1.87 over the past 52 weeks
Poseida Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Poseida Therapeutics?
-
How Much Debt Does Poseida Therapeutics Have?
Total long term debt quarterly is $58.9M -
How Much Cash Does Poseida Therapeutics Have?
Cash and short term investments quarterly total is $230.9M -
What Is Poseida Therapeutics’s Book Value Per Share?
Book value per share is 0.90
Is Poseida Therapeutics Cash Flow Positive?
-
What Is PSTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$15M -
What Is Poseida Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $699K -
What Is Poseida Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $38.2M
Poseida Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PSTX return on invested capital is -40.32% -
What Is Poseida Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -21.23% -
What Is PSTX Return On Equity?
ROE is a measure of profitability and is -66.05%
Poseida Therapeutics Earnings Date & Stock Price
-
What Is Poseida Therapeutics's Stock Price Today?
A single share of PSTX can be purchased today for 2.76 -
What Is Poseida Therapeutics’s Stock Symbol?
Poseida Therapeutics trades on the nasdaq under the ticker symbol: PSTX -
When Is Poseida Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Poseida Therapeutics is scheduled on March 7, 2025 -
When Is PSTX's next ex-dividend date?
Poseida Therapeutics's next ex-dividend date is November 17, 2024 -
How To Buy Poseida Therapeutics Stock?
You can buy Poseida Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Poseida Therapeutics Competitors
-
Who Are Poseida Therapeutics's Competitors?
Below is a list of companies who compete with Poseida Therapeutics or are related in some way:
Poseida Therapeutics Dividend Yield
-
What Is PSTX Dividend Yield?
Poseida Therapeutics’s dividend yield currently is 0% -
What Is Poseida Therapeutics’s Payout Ratio?
Poseida Therapeutics’s payout ratio is 0% -
When Did Poseida Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 17, 2024 -
What Is Poseida Therapeutics’s Dividend Per Share?
Poseida Therapeutics pays a dividend of $0.00 per share
Poseida Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 149.61% |
| Revenue: | 667.19% | 341.53% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 14.00 |
| Upside from Last Price: | 407.25% |